These Alzheimer’s drugs were supposed to revolutionize the way we fight the disease. The reality is more complicated.
A scientific report has raised questions about how much Leqimbi and Kisunla — the “breakthrough” Alzheimer’s drugs that have hit […]
‘I hope to retire at 59’: I have $950,000 in my 401(k)s. When do I do a Roth conversion?
Roth conversions are permanent. Once done, they cannot be undone.
Trump expects his Fed chair nominee to cut interest rates. Here’s how Kevin Warsh might try to do it.
Warsh will be pressed on his outlook for rates at his Senate confirmation hearing Tuesday.
Reed Hastings created a work culture that made Netflix a giant. Can it survive without him?
Hastings insisted that employees be ready to give and receive constructive criticism at all times and that people should be […]
The real outcome of the Iran war: America is now the world’s most secure energy power
Trump’s message is ‘buy American’ — the U.S. has fuel and is a safe alternative to the Gulf
These two sectors have been boosted by AI hopes. Why investors should buy one, and trim exposure to the other.
Technology has lifted the market higher and has further to go, says Ned Davis Research
Mutual insurance companies are sending record-breaking cash payouts to their customers this year. Is using one right for you?
While most carriers pocket your premiums, mutual-insurance companies are owned by their customers.
U.S. oil prices drop below $83 a barrel after Iran declares Strait of Hormuz ‘completely open’ during cease-fire
Oil prices were falling on Friday morning after Iran’s foreign minister said the Strait of Hormuz is declared open for […]
Even OpenAI’s top economist thinks the AI job apocalypse is overstated. Here’s why.
OpenAI has done an in-depth study at just what AI disruption means for the jobs market, pushing back at some […]
Lilly’s new GLP-1 pill is off to a ‘robust’ start
Lilly’s new GLP-1 pill had 1,390 prescriptions in its first week on the market.
